Receptors, Mineralocorticoid
"Receptors, Mineralocorticoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone.
MeSH Number(s)
D12.776.260.698.750.530
D12.776.826.750.530
D12.776.930.669.750.530
Concept/Terms
Receptors, Mineralocorticoid- Receptors, Mineralocorticoid
- Mineralocorticoid Receptors
- Mineralocorticoid Receptor
- Receptor, Mineralocorticoid
- Receptors, Mineralocorticoids
- Mineralocorticoids Receptors
Receptors, Corticoid Type I- Receptors, Corticoid Type I
- Corticoid Type I Receptors
- Corticoid I Receptor
- Receptor, Corticoid I
- Receptors, Corticoid I
- Corticoid I Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Mineralocorticoid".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- DNA-Binding Proteins [D12.776.260]
- Receptors, Cytoplasmic and Nuclear [D12.776.260.698]
- Receptors, Steroid [D12.776.260.698.750]
- Receptors, Mineralocorticoid [D12.776.260.698.750.530]
- Receptors, Cytoplasmic and Nuclear [D12.776.826]
- Receptors, Steroid [D12.776.826.750]
- Receptors, Mineralocorticoid [D12.776.826.750.530]
- Transcription Factors [D12.776.930]
- Receptors, Cytoplasmic and Nuclear [D12.776.930.669]
- Receptors, Steroid [D12.776.930.669.750]
- Receptors, Mineralocorticoid [D12.776.930.669.750.530]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Mineralocorticoid".
This graph shows the total number of publications written about "Receptors, Mineralocorticoid" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Mineralocorticoid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 2 | 1 | 3 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2010 | 1 | 3 | 4 |
2011 | 7 | 0 | 7 |
2012 | 3 | 1 | 4 |
2013 | 2 | 1 | 3 |
2014 | 2 | 2 | 4 |
2015 | 3 | 0 | 3 |
2016 | 0 | 1 | 1 |
2017 | 3 | 2 | 5 |
2018 | 2 | 1 | 3 |
2019 | 3 | 1 | 4 |
2020 | 1 | 0 | 1 |
2021 | 2 | 3 | 5 |
2022 | 1 | 2 | 3 |
2023 | 0 | 5 | 5 |
2024 | 0 | 2 | 2 |
Below are the most recent publications written about "Receptors, Mineralocorticoid" by people in Profiles.
-
Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators? Circulation. 2024 Feb 06; 149(6):414-416.
-
Mineralocorticoid Receptor Antagonism by Eplerenone and Arterial Inflammation in HIV: The MIRABELLA HIV Study. JAMA Cardiol. 2024 Feb 01; 9(2):189-194.
-
Blockade of the mineralocorticoid receptor improves markers of human endothelial cell dysfunction and hematological indices in a mouse model of sickle cell disease. FASEB J. 2023 08; 37(8):e23092.
-
Non-steroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease. Nephrol Dial Transplant. 2023 03 31; 38(4):845-854.
-
Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II. Int J Mol Sci. 2023 Mar 30; 24(7).
-
Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension. Circulation. 2023 03 28; 147(13):991-992.
-
Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia. Circ Res. 2023 03 17; 132(6):674-689.
-
Aldosterone in chronic kidney disease and renal outcomes. Eur Heart J. 2022 10 11; 43(38):3781-3791.
-
Finerenone: A New Era for Mineralocorticoid Receptor Antagonism and Cardiorenal Protection. Curr Probl Cardiol. 2022 Dec; 47(12):101386.
-
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. Eur Heart J. 2022 08 14; 43(31):2931-2945.